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droplets” [Virology 399 (2) (2010) 322–331]Gunhild Unterstab a, Julia Manzetti a, Hans H. Hirsch a,b,n
a Transplantation & Clinical Virology, Department Biomedicine (Haus Petersplatz), University of Basel, Petersplatz 10, CH-4003 Basel, Switzerland
b Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Petersgraben 4, CH-4031 Basel, SwitzerlandIn our publication “The polyomavirus BK agnoprotein co-localizes with lipid droplets” (Unterstab et al., 2010 Virology 399:322–31), we
reported that the BKV agnoprotein co-localizes with lipid droplets (LD), but not with the endoplasmic reticulum (ER) (Unterstab et al.,
2010). In that study, we detected transiently expressed His-tagged BKV agnoprotein (agno-His) in Vero cells using a monoclonal His-tag
antibody (DIA900, Dianova, Hamburg, Germany) together with a rabbit antiserum against the ER marker protein calnexin (ADI-SPA860,
Enzo Life Sciences, Lausen, Switzerland). In confocal microscopy analysis, we were unable to detect signiﬁcant overlapping signals of BKV
agnoprotein and calnexin (see Supplementary ﬁgure 1a in Unterstab et al., 2010).Co-localization studies for BKV agnoprotein and the ER-localized protein disulﬁde isomerase (PDI). Immunoﬂuorescence analysis of UTA-6 cells expressing
oprotein under a tetracycline-repressible (Tet-off) promoter after ﬁxing the cells with 4% paraformaldehyde (RT, 10 min). (a) Detection of the agnoprotein; (b) PDI;
ed channels (Bar 20 μm); (d) Z-slice of a deconvolved 3D image of the indicated area, after co-localization analysis. Co-localizing pixels are shown in a new channel,
(e) volume with isosurface rendering of the co-localization channel; (f) Scatterplot/2D histogram displaying the Pearson coefﬁcient.
22/$ - see front matter & 2013 Elsevier Inc. All rights reserved.
x.doi.org/10.1016/j.virol.2013.03.018
of original article: http://dx.doi.org/10.1016/j.virol.2010.01.011
esponding author at: Department Biomedicine (Haus Petersplatz), University of Basel, Petersplatz 10, CH-4003 Basel, Switzerland. Fax: +41 61 267 3283.
ail address: hans.hirsch@unibas.ch (H.H. Hirsch).
Fig. 2. Co-localization studies for BKV agnoprotein and the ER-localized PDI in BKV Dunlop infected RPTECs at 2 days post infection. (a) Detection of the agnoprotein; (b) PDI;
(c) merged channels (bar 20 μm); (d) volume of a deconvolved 3D image of the indicated area, after co-localization analysis. Co-localizing pixels are shown in a new channel,
yellow; (e) Volume with isosurface rendering of the co-localization channel, yellow; (f) Scatterplot/2D histogram displaying the Pearson coefﬁcient.
Fig. 3. Co-localization studies for BKV agnoprotein and the ER-localized protein calnexin. Immunoﬂuorescence analysis of UTA-6 cells expressing BKV-agnoprotein under a
tetracycline-repressible (Tet-off) promoter after ﬁxing the cells with 4% paraformaldehyde (RT, 10 min). (a) Detection of the agnoprotein; (b) calnexin; (c) merged channels
(Bar 20 μm); (d) Z-slice of a deconvolved 3D image of the indicated area, after co-localization analysis. Co-localizing pixels are shown in a new channel, yellow; (e) Volume
with isosurface rendering of the co-localization channel, yellow; (f) Scatterplot/2D histogram displaying the Pearson coefﬁcient.
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indeed co-localizes with LD, but also with the ER. This ER co-localization was demonstrated in BKV (Dunlop)-infected primary human proximal
tubular epithelial cells (hRPTECs) as well as in UTA-6 cells 2C9 stably expressing Tet-off regulated BKV-agnoprotein at 48 h after tetracycline
removal (Cioni et al., in press). BKV agnoprotein was stained together with the ER marker protein protein disulﬁde isomerase (PDI) using an
anti-BKV agnoprotein serum (Rinaldo et al., 1998) and a monoclonal antibody (ADI-SPA-891, 1:250, Enzo Life Sciences, Lausen, Switzerland),
respectively. After stack acquisitionwith 44 z-slices (voxel xyz size¼30, 30, 130 nm), de-convolution, and image analysis with Imaris, we clearly
detected co-localization of both proteins. Deﬁning a third channel (yellow), which displayed areas of overlapping signals yielded an almost ideal
(1.0) Pearson coefﬁcient of 0.9134 (Fig. 1). Similar results were obtained with the ER-marker calreticulin using the chicken polyclonal serum
(ab14234, 1:500, abcam, Cambridge, UK; Supplementary Fig. 1). Importantly, BKV agnoprotein co-localization was detected in hRPTECs at 2d
post infection with BKV Dunlop (Fig. 2).
To investigate the discrepancy between our previous and present observations, we also re-examined co-localization using a new lot of
the anti-calnexin antiserum (ADI-SPA860, 1:200, Enzo Life Sciences, Lausen, Switzerland) described in our original article, for the detection
of the ER in UTA-6 cells transiently expressing Flag-tagged BKV agnoprotein (anti-Flag M2 mab, 1:500, Sigma Aldrich, Buchs, Switzerland).
This independently demonstrated co-localization of BKV agnoprotein and calnexin (Fig. 3).
The reason for the inconsistency with our previously published data is not clear, but might be attributable to lot-speciﬁc issues of the
calnexin antiserum and/or to the His-tagged BKV agnoprotein construct. We wish to sincerely apologize for potentially negative effects of
our report and hope that our clariﬁcation of the BKV agnoprotein co-localization will help to spawn further research resolving the as yet
unclear role of BKV agnoprotein.Appendix A. Supplementary material
Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.virol.2013.03.018.References
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